Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
HXB:FRA
AIM ImmunoTech Inc
-100.00%
(-6.10) 1D
Jan 8, 12:00:59 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HXB...
Mkt. cap
4.25M
Volume
0.00
52-wk high
€22.00
52-wk low
€6.10
No. of employees
20
News stories
From sources across the web
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorBiotechnology
Websiteaimimmuno.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
16.00K
25.00K
26.00K
21.00K
Cost of goods sold
10.00K
10.00K
68.00K
40.00K
Cost of revenue
10.00K
10.00K
68.00K
40.00K
Research and development expenses
972.00K
1.17M
607.00K
999.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.65M
1.49M
1.80M
1.93M
Operating expense
3.62M
2.66M
2.40M
2.93M
Total operating expenses
3.64M
2.67M
2.47M
2.97M
Operating income
-3.62M
-2.65M
-2.45M
-2.95M
Other non operating income
-
-
-3.74M
-942.00K
EBT including unusual items
-3.70M
-2.79M
-3.28M
-4.18M
EBT excluding unusual items
-3.73M
-2.78M
-6.32M
-4.18M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.70M
-2.79M
-3.28M
-4.18M
Net profit margin
-23,156.25%
-11,176.00%
-12,630.77%
-19,880.95%
Earnings per share
-5.00
-3.68
-1.57
-0.44
Interest and investment income
11.00K
10.00K
11.00K
110.00K
Interest expense
-124.00K
-149.00K
-148.00K
-391.00K
Net interest expenses
-113.00K
-139.00K
-137.00K
-281.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.56M
-2.59M
-2.39M
-2.91M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer